Ensign Group Inc header image

Ensign Group Inc

ENSG

Equity

ISIN US29358P1012 / Valor 3109721

NASDAQ (2024-09-18)
USD 151.00-0.68%

Ensign Group Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

The Ensign Group, Inc. operates through its independent subsidiaries, offering a comprehensive range of services across the healthcare spectrum, particularly focusing on post-acute care. This includes skilled nursing and assisted living facilities, alongside a variety of rehabilitative services such as physical, occupational, and speech therapies. Expanding beyond its traditional scope, The Ensign Group has ventured into additional post-acute care services, which encompass mobile x-ray, laboratory services, non-emergency transportation, and consulting services. These offerings are designed to meet a broad array of patient needs across several states, indicating The Ensign Group's commitment to providing a holistic approach to healthcare and rehabilitation.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.08.2024):

Revenue Growth

Ensign Group Inc. reported consolidated GAAP and adjusted revenue of $1.04 billion for the second quarter of 2024, marking a 12.5% increase over the prior year quarter. This growth was driven by a rise in skilled services revenue and managed care revenue across their facilities.

Earnings Per Share

For the second quarter of 2024, Ensign Group Inc. achieved GAAP diluted earnings per share of $1.22, an 8.9% increase from the previous year. Adjusted earnings per share were reported at $1.32, reflecting a 13.8% rise over the same period last year.

Net Income

Ensign Group Inc. reported a GAAP net income of $71.0 million for the second quarter of 2024, which is an 11.0% increase compared to the prior year quarter. The adjusted net income for the same period was $76.4 million, showing a 15.3% increase year-over-year.

Occupancy Rates

During the second quarter of 2024, Ensign Group Inc. saw an increase in occupancy rates, with Same Facilities occupancy reaching 80.8%, a 2.8% rise over the prior year quarter. Transitioning Facilities also experienced a 4.3% increase in occupancy.

Annual Guidance

Ensign Group Inc. raised its annual earnings guidance for 2024 to between $5.38 to $5.50 per diluted share, up from the previous range of $5.29 to $5.47. The company also increased its annual revenue guidance to between $4.20 billion to $4.22 billion, reflecting confidence in continued growth and strong performance.

Summarized from source with an LLMView Source

Key figures

61.0%1Y
93.6%3Y
258%5Y

Performance

20.9%1Y
26.4%3Y
40.5%5Y

Volatility

Market cap

8683 M

Market cap (USD)

Daily traded volume (Shares)

116,187

Daily traded volume (Shares)

1 day high/low

154.08 / 150.43

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

KK Noevir Holdings
KK Noevir Holdings KK Noevir Holdings Valor: 11962363
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%JPY 5,320.00
Spire Healthcare Group PLC
Spire Healthcare Group PLC Spire Healthcare Group PLC Valor: 24881418
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.26%GBP 2.35
Kaken Seiyaku KK
Kaken Seiyaku KK Kaken Seiyaku KK Valor: 762167
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%JPY 3,915.00
KK B.M.L
KK B.M.L KK B.M.L Valor: 789977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.56%JPY 2,678.00
Towa Yakuhin KK
Towa Yakuhin KK Towa Yakuhin KK Valor: 248084
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.06%JPY 2,958.00
Novartis Inc
Novartis Inc Novartis Inc Valor: 567514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%USD 115.97
GSK PLC
GSK PLC GSK PLC Valor: 120042705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.31%USD 42.43
GSK PLC
GSK PLC GSK PLC Valor: 119642297
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%GBP 16.04
Royalty Pharma PLC
Royalty Pharma PLC Royalty Pharma PLC Valor: 55041695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.11%USD 28.21
Olaplex Holdings Inc
Olaplex Holdings Inc Olaplex Holdings Inc Valor: 113471584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.65%USD 2.62